4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 95.0%, 10g

Sodium carbonate decahydrate, min. 99%, pa, ISO, 500 g, plastic packaging.

2-[5-(3-bromophenyl)-1H-pyrazol-3-yl]phenol, 95.0%, 1g

N-Butylbenzylamine>97.0%(GC)(T)25mL

(5-Chlorobenzofuran-2-yl)boronic acid, 95.0%, 100mg

1-Bromo-3-chloro-2-methylpropane, 95.0%, 1g

(S)-tert-Butyl 2-amino-5-(((benzyloxy)carbonyl)amino)pentanoate hydrochloride, 95.0%, 25g

3,5-Dichlorophenylhydrazine hydrochloride, 97.0%, 10g

5-Bromo-3-((trimethylsilyl)ethynyl)pyrazin-2-amine, 95.0%, 10g

(E)-N-(4-((4-Chloro-3-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide (Dacomitinib Impurity), 97%, 50mg

(2,3,4,6-Tetrafluorophenyl)methanol, 98%, 1g

4-BROMO-2,7-DIMETHYL-2H-INDAZOLE, 95.0%, 250mg

2,2,3,3-Tetramethylsuccinic acid, 95.0%, 5g